Tech-Transfer and Manufacturing for Scaling Biotech
April 27, 2026
At Advanced Therapies Week 2026, our Chief Technology Officer, Gregg Nyberg, joined a panel of industry leaders to discuss how...
Read more →In the first three posts in this series, we covered the manufacturing landscape for advanced therapies, the importance of modality-specific expertise and development integration,...
Read More →April 27, 2026
At Advanced Therapies Week 2026, our Chief Technology Officer, Gregg Nyberg, joined a panel of industry leaders to discuss how...
Read more →April 02, 2026
Your science is ready.
The mechanism is well-characterized, the preclinical data is compelling, and the clinical development...
Read more →